Statement 21 March 2022

Joint Industry Statement on the War in Ukraine


21 March 2022 – The global research-based pharmaceutical industry stands in solidarity with the people of Ukraine and condemns the invasion of their country and the suffering it continues to cause. Overcoming the challenges that this unprecedented humanitarian crisis poses for patients is our main concern.

We are united in our mission of providing treatments and vaccines to all those affected by the war, wherever they are. Safe passage of medical products remains a top priority.

The industry is working in a variety of ways to support those affected by the unfolding humanitarian crisis. This includes providing free essential medicines and giving financial support to NGOs on the ground. We are monitoring for supply chain disruptions and building supply capacity where it’s needed as well as working with the wider health community to address issues as they arise.

To learn more about individual company efforts, please visit the website set up by the European Federation of Pharmaceutical Industries and Associations’ (EFPIA), found here.


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster